Creative Biosciences is an advanced bio-tech enterprise founded by a team of excellent scientists. Since its registration in January 2015, CreativeBio has been dedicated in research and development of Colosafe^®, a sDNA test for early detection of colorectal cancer, as well as in manufacturing, sales, and its related automation equipment. Other early detection kits for various cancers are in development and will be in the market soon. With its headquarter located in Guangzhou High-Tech Industry Development Zone, CreativeBio owns R&D lab，GMP manufacturing facilities, integrated offices, and three testing labs scattered in Guangzhou, Tianjin, Jinan, covering more than 18,000㎡ in total. In March 2020, CreativeBio acquired Helixgen, which has enhanced its R&D team and capacity ever since. The company not only possesses independent intellectual property rights but also boasts its world top-notch R&D capability which will be improved and transformed into productivity in the future. On top of Colosafe^®, other noninvasive early detection kits for lung, bladder, cervical, liver cancers, together with POCT products have reached amazing development.

By far, CreativeBio has completed several rounds of venture capital fundraising and won tremendous support from government at all levels. Evidently it has emerged as a notable star in the industry. Guided by the ultimate goal of “Human Health, My Mission”, CreativeBio is striving to make breakthroughs in early diagnosis, early intervention, and prognosis monitoring of chronicle diseases specifically in cancer, to benefit all nations.